Identification and validation of novel prognostic biomarkers and therapeutic targets for non-small cell lung cancer

Background: Despite the significant survival benefits of anti-PD-1/PD-L1 immunotherapy, non-small cell lung cancer (NSCLC) remains one of the most common tumors and major causes of cancer-related deaths worldwide. Thus, there is an urgent need to identify new therapeutic targets for this refractory...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Li-Ting, Ren, Yuan-Hui, Huai, Ya-Jun, Liu, Yu, Liu, Ying, Wang, Shan-Shan, Mei, Jin-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060803/
https://www.ncbi.nlm.nih.gov/pubmed/37007961
http://dx.doi.org/10.3389/fgene.2023.1139994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060803/
https://www.ncbi.nlm.nih.gov/pubmed/37007961
http://dx.doi.org/10.3389/fgene.2023.1139994

Ejemplares similares